首页 | 官方网站   微博 | 高级检索  
     

多中心型Castleman病的研究进展
引用本文:张常晓,朱锋,徐开林.多中心型Castleman病的研究进展[J].国际输血及血液学杂志,2017,40(5).
作者姓名:张常晓  朱锋  徐开林
作者单位:221000,江苏徐州医科大学附属医院血液科
基金项目:81600145)国家自然科学基金
摘    要:Castleman病,又称为巨大淋巴结增生症或者血管淋巴性滤泡组织增生,该病为一种少见的异质性淋巴组织增生性疾病.目前,对Castleman病的文献报道多为小样本量或者个案研究,而研究主要集中于多中心型Castleman病(MCD)的发病机制及其治疗方面,并且取得了一些新的进展.笔者拟就MCD的病因及发病机制、临床表现、诊断及治疗等方面的研究进展进行综述.

关 键 词:巨淋巴结增生  淋巴组织增殖性疾病  中心型Castleman病

Research progress of multicentric Castleman disease
Zhang Changxiao,Zhu Feng,Xu Kailin.Research progress of multicentric Castleman disease[J].International Journal of Blood Tranfusion and Hematology,2017,40(5).
Authors:Zhang Changxiao  Zhu Feng  Xu Kailin
Abstract:Castleman disease is also known as giant lymph node hyperplasia or angiofollicular lymph node hyperplasia,which is a rare heterogeneous disease of lymphoid tissue.At present,reports related to Castleman disease are mostly small cases or case studies,which mainly focus on pathogenesis and treatment of multicenter Castleman disease (MCD),and some new developments have been achieved.Now,the research progress of the etiology,pathogenesis,clinical manifestation,diagnosis and treatment of MCD are reviewed.
Keywords:Giant lymph node hyperplasia  Lymphoproliferative disorders  Multicenter Castleman disease
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号